MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...

World Cancer Day aims to raise awareness for the prevention, detection, and treatment of all kinds of cancers, with ...

Penn-Trafford sophomore Abby Rayman is on a mission to raise $10,000 to support children diagnosed with leukemia and lymphoma ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...